Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 3Thoracic 1Sarcoma 1Gynecologic 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma 1Ovarian Neoplasms 1Melanoma 1Liposarcoma 1Leiomyosarcoma 1Endometrial Neoplasms 1Colorectal Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Endometrioid 1Carcinoma, Ductal 1Adenocarcinoma 1

Interventions

pembrolizumab 59Nivolumab 34Cyclophosphamide 21fludarabine 15Paclitaxel 12Ipilimumab 12atezolizumab 11Specimen Handling 11Magnetic Resonance Spectroscopy 10Carboplatin 10Docetaxel 9Cisplatin 9Gemcitabine 8Biopsy 8durvalumab 7aldesleukin 7Radiosurgery 7Interleukin-2 7Bevacizumab 7cemiplimab 6Pemetrexed 6fludarabine phosphate 5avelumab 5Radiotherapy 5Drug Therapy 5spartalizumab 4epacadostat 4enzalutamide 4Taxes 4Sirolimus 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Melanoma × Radiation, Ionizing × Gastrointestinal × Clear all
NCT00132704 2014-07-24

An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation

Memorial Sloan Kettering Cancer Center

Completed
149 enrolled
DermatologicGastrointestinalGynecologicSarcomaThoracic

Adenocarcinoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Leiomyosarcoma, Liposarcoma, Melanoma, Ovarian Neoplasms, Sarcoma, Colorectal Neoplasms, Endometrial Neoplasms, Carcinoma, Endometrioid, Carcinoma, Ductal, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡